New photodynamic therapy with next-generation photosensitizers
- PMID: 28616398
- PMCID: PMC5464935
- DOI: 10.21037/atm.2017.03.59
New photodynamic therapy with next-generation photosensitizers
Abstract
Photodynamic therapy (PDT) is a non-invasive antitumor treatment that uses the combination of a photosensitizer, tissue oxygen, and visible light irradiation to produce cytotoxic reactive oxygen species, predominantly singlet oxygen. Currently, first-generation PDT using porfimer sodium with an excimer dye laser, and second-generation PDT using talaporfin sodium PDT with a semiconductor laser are approved by health insurance for use in Japan. However, the cancer cell specificity and selectivity of these treatments are inadequate. Cancer cells consume higher levels of glucose than normal cells and this phenomenon is known as the Warburg effect. Thus, we developed a third-generation PDT, based on the Warburg effect, by synthesizing a novel photosensitizer, sugar-conjugated chlorin, with increased cancer cell-selective accumulation. Glucose-conjugated chlorin (G-chlorin) PDT showed significantly stronger antitumor effects than second-generation talaporfin PDT. We also found that PDT with G-chlorin induced immunogenic cell death which is characterized by the secretion, release, or surface exposure of damage-associated molecular patterns (DAMPs), including calreticulin (CRT) and the high-mobility group box 1 (HMGB1) protein. Mannose-conjugated chlorin (M-chlorin) PDT which targets the mannose receptors on the surface of cancer cells and tumor-associated macrophages (TAMs) in cancer tissue stroma also showed very strong antitumor effects. These novel PDTs using glucose or M-chlorins stand as new candidates for very effective, next-generation PDTs.
Keywords: Photodynamic therapy (PDT); Warburg effect; chlorin; photosensitizer; tumor-associated macrophage (TAM).
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Potential of Photodynamic Therapy Based on Sugar-Conjugated Photosensitizers.J Clin Med. 2021 Feb 18;10(4):841. doi: 10.3390/jcm10040841. J Clin Med. 2021. PMID: 33670714 Free PMC article. Review.
-
Excellent antitumor effects for gastrointestinal cancers using photodynamic therapy with a novel glucose conjugated chlorin e6.Biochem Biophys Res Commun. 2018 Feb 19;496(4):1204-1209. doi: 10.1016/j.bbrc.2018.01.171. Epub 2018 Jan 31. Biochem Biophys Res Commun. 2018. PMID: 29408755
-
A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.Oncotarget. 2016 Nov 8;7(45):74259-74268. doi: 10.18632/oncotarget.12366. Oncotarget. 2016. PMID: 27708235 Free PMC article.
-
Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).Oncotarget. 2016 Jul 26;7(30):47242-47251. doi: 10.18632/oncotarget.9725. Oncotarget. 2016. PMID: 27363018 Free PMC article.
-
[History of photodynamic therapy--past, present and future].Gan To Kagaku Ryoho. 1996 Jan;23(1):8-15. Gan To Kagaku Ryoho. 1996. PMID: 8546474 Review. Japanese.
Cited by
-
Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities.Front Oncol. 2022 Sep 23;12:980239. doi: 10.3389/fonc.2022.980239. eCollection 2022. Front Oncol. 2022. PMID: 36212416 Free PMC article. Review.
-
From Basic Mechanisms to Clinical Research: Photodynamic Therapy Applications in Head and Neck Malignancies and Vascular Anomalies.J Clin Med. 2021 Sep 26;10(19):4404. doi: 10.3390/jcm10194404. J Clin Med. 2021. PMID: 34640423 Free PMC article. Review.
-
Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.Cells. 2020 May 21;9(5):1277. doi: 10.3390/cells9051277. Cells. 2020. PMID: 32455737 Free PMC article.
-
Near-infrared absorbing Ru(ii) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma.Chem Sci. 2020 Sep 9;11(43):11740-11762. doi: 10.1039/d0sc03875j. eCollection 2020 Nov 21. Chem Sci. 2020. PMID: 33976756 Free PMC article.
-
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.Chem Rev. 2019 Jan 23;119(2):797-828. doi: 10.1021/acs.chemrev.8b00211. Epub 2018 Oct 8. Chem Rev. 2019. PMID: 30295467 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials